Prelude Therapeutics Incorporated (PRLD) has a market capitalization of $245.2M and trades at $4.40. The 52-week range is 0.61-4.22.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.4, Earnings Per Share (EPS) of $-1.29, annual revenue of $12.14M.
The stock has a beta of 0.72, operates in the Healthcare sector.
